Triple negative breast cancer (TNBC) is defined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) overexpression, which accounts for 15–20 % of breast cancer patients (Perou et al. 2000). Here, ERBB2 is linked to breast cancer.